Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11 Tumor-Agnostic 1 Other 1 Genitourinary 1

Conditions

Sexual Dysfunction, Physiological 1

Interventions

Radiotherapy 5 Surveys and Questionnaires 4 Cisplatin 4 angiotensin I (1-7) 3 alvimopan 3 Radiation 3 Injections 3 Water 2 Vitamin D 2 Tirzepatide 2 RRx-001 2 Mouthwashes 2 Metformin 2 Interleukin 1 Receptor Antagonist Protein 2 High-Intensity Focused Ultrasound Ablation 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Calcium Dobesilate 2 Amifostine 2 Acetylcysteine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 naloxegol 1 methylnaltrexone 1 methyl N-acetylsibirosaminide 1 linaclotide 1 licogliflozin 1 kang-lai-te 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Estradiol × Other × Clear all

NCT00698035 2014-06-02

E-String

University of California, San Francisco

Phase 2 Completed

76 enrolled 11 charts

Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon ⚡